Is glucose variability an independent predictor of mortality in hospitalized patients treated with total parenteral nutrition?
High GV is associated with increased hospital mortality independent of the presence and severity of hyperglycemia or hypoglycemia during TPN therapy. Prospective randomized trials are needed to determine if reduction in GV with intensive glycemic control improves clinical outcomes in patients treated with TPN.
There is racial/ethnic disparity in outcome after selected EGS; however, this disparity is explained by hospital-level factors.